Communication Committee
Communication committee

Carolina Catarino
Bioprocess Engineer and Biotechnologist with a Master's in Clinical Analysis from the University of São Paulo and a PhD in Chemical Engineering from Rensselaer Polytechnic Institute (USA). Actively involved in outreach initiatives promoting alternative testing methods, her expertise focuses on developing reconstructed skin models using 3D bioprinting and applying alternative methods for the safety assessment of materials. Currently serving as Principal Scientist at Grupo Boticário, leading the alternative methods laboratory and preclinical evaluation team.

Lorena Neves
Lorena Neves is a Ph.D. candidate in Translational Biomedicine at the University of Greater Rio and a researcher at the Eukaryotic Cell Biology Laboratory, at the National Institute of Metrology Quality and Technology - INMETRO. Master’s degree in Biotechnology (INMETRO) and is a Specialist in Alternative Methods to animal use in laboratories (Oswaldo Cruz Foundation - Fiocruz), she focuses on human-based and animal product-free approaches to in vitro methods. Lorena's research aims to find sustainable and ethical answers in the safety evaluation of chemicals, investigating the advantages of animal-origin-free solutions.
In 2018, she was awarded the prestigious Lush Prize in the Young Researchers category for her contributions to replacing animal-derived products in research. Since 2021, she has produced content on social media to disseminate in vitro tests and New Approach Methodologies.

Artur Silva
Artur Silva is an Associate Professor of Pharmaceutical Bioengineering at the Faculty of Pharmacy, Federal University of Goiás (UFG). He holds a degree in Pharmacy and a Ph.D. in Pharmaceutical Sciences from UFG, with a doctoral research exchange at the Technical University of Berlin. His research focuses on developing and applying physiologically relevant in vitro models for the preclinical assessment of pharmaceutical products and Advanced Therapy Medicinal Products (ATMPs), with an emphasis on ocular and pulmonary systems. Additionally, he is actively working on bioengineering strategies to develop microphysiological systems for disease modeling and the replacement of animal models in drug efficacy studies. He also serves as the secretary of the Organs-on-a-Chip and Biofabrication TWIG of the Tissue Engineering and Regenerative Medicine International Society (TERMIS).